Kidney Transplant clinical trials at UC Cancer

• Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

  open to eligible people ages 18-70

  The primary objective of this study is to demonstrate the safety and efficacy of cellular immunotherapy with MDR-101 for induction of functional immune tolerance in recipients of human leukocyte antigen (HLA)-matched, living donor kidney transplants.

  at UC Davis UCSD UCSF

Last updated: August 24, 2020